Riyadh, August 04, 2025, SPA -- The Saudi Food and Drug Authority (SFDA) has approved the registration of Pyrukynd (Mitapivat) for the treatment of adult patients with alpha- or beta-thalassemia, ...

India, often referred to as the Thalassemia capital of the world due to its highest number of children affected by ...

The Federation of Obstetric and Gynaecological Societies of India (FOGSI) and Veha Foundation on Thursday launched the ...

An initiative to make thalassemia screening a routine part of antenatal care and ensure its diagnosis and prevention in the country has been launched, according to those associated with the efforts.

The Federation of Obstetric and Gynaecological Societies of India (FOGSI) and Veha Foundation, a non-profit company, unveiled ...

The study, “ Risk of cancer in patients with thalassemia and sickle cell disease: a systematic review,” was published in the Annals of Medicine. A genetic disorder, SCD features the production of an ...

Punjab Health and Family Welfare Minister Dr Balbir Singh, with the support of the Philanthropy Club, Sunday inaugurated a fully equipped modern thalassemia Ward at Civil Hospital, Ludhiana. This ward ...

Blood transfusion services for thalassemia patients were abruptly disrupted on Saturday at the Thalassemia Center due to the absence of a power backup system, following a major electricity outage ...

Dozens of families dependent on Lok Nayak Hospital for free thalassemia care have been left anxious after learning that the facility may soon discontinue treatment for patients above 12 years of ...

Gedeon Richter UK has launched Nalvee (10mg dydrogesterone) in the UK, marking the return of a dydrogesterone-only formulation for hormone replacement therapy after more than 17 years. The oral tablet ...

The Saudi Food and Drug Authority (SFDA) has approved Agios' Pyrukynd (mitapivat) for adults with alpha or beta-thalassemia.

First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the ...